Bristol Myers Squibb Co. (BMY)
54.29
+1.88
(+3.59%)
USD |
NYSE |
Dec 15, 16:00
54.55
+0.26
(+0.48%)
After-Hours: 19:23
Bristol Myers Squibb Research and Development Expense (Annual): 9.782B for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen, Inc. | 5.676B |
| Gilead Sciences, Inc. | 5.816B |
| Johnson & Johnson | 17.26B |
| Eli Lilly & Co. | 10.99B |
| Regeneron Pharmaceuticals, Inc. | 4.624B |